Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome

The aim of the present study was to compare the reproductive outcomes of letrozole and laparoscopic ovarian drilling (LOD) in women with clomiphene citrate (CC)-resistant polycystic ovary syndrome (PCOS). A total of 141 women with CC-resistant PCOS were enrolled and randomly allocated into groups A and B. Group A (n=71) received 2.5 mg letrozole from days 5 to 10 of menses for up to six cycles, and group B (n=70) underwent LOD. A 6-month follow-up was performed. No statistically significant difference was found in the baseline clinical characteristics and the major serum hormone profiles, including luteinizing hormone, follicle-stimulating hormone, estradiol and free testosterone, between the two groups. Women receiving letrozole had a lower rate of spontaneous abortion (6.9 vs. 15.8%) and higher clinical pregnancy (40.8 vs. 27.1%) and live birth (38.0 vs. 22.9%) rates; however, the differences were not statistically significant. Letrozole had superior reproductive outcomes compared with LOD in women with CC-resistant PCOS; therefore, letrozole could be used as the first-line treatment for women with CC-resistant PCOS.

[1]  Hai-yan Wang,et al.  A Comparison of the Efficacy of Two Doses of Letrozole Alone or with Continuous Recombinant Follicle-Stimulating Hormone for Ovulation Induction in Anovulatory Women , 2014, Gynecologic and Obstetric Investigation.

[2]  I. Salah.  Office microlaparoscopic ovarian drilling (OMLOD) versus conventional laparoscopic ovarian drilling (LOD) for women with polycystic ovary syndrome , 2013, Archives of Gynecology and Obstetrics.

[3]  R. Casper,et al.  Use of the Aromatase Inhibitor Letrozole for Ovulation Induction in Women With Polycystic Ovarian Syndrome , 2011, Clinical obstetrics and gynecology.

[4]  F. Ramezanzadeh,et al.  A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS , 2011, Archives of Gynecology and Obstetrics.

[5]  Mohamad S. Abdellah.  Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene‐resistant polycystic ovary syndrome , 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[6]  F. Azizi,et al.  The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study , 2011, Reproductive biology and endocrinology : RB&E.

[7]  S. Hendawy,et al.  Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination , 2011, Clinical medicine insights. Reproductive health.

[8]  A. Badawy,et al.  Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial , 2010, Archives of Gynecology and Obstetrics.

[9]  F. Zullo,et al.  Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance , 2009, Current opinion in obstetrics & gynecology.

[10]  Julie Brown,et al.  Clomiphene and anti-oestrogens for ovulation induction in PCOS. , 2009, The Cochrane database of systematic reviews.

[11]  K. Roy,et al.  Endometrial effects of letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery Doppler , 2009, Archives of Gynecology and Obstetrics.

[12]  Huiman X Barnhart,et al.  Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. , 2007, The New England journal of medicine.

[13]  T. Kruger,et al.  Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. , 2006, Fertility and sterility.

[14]  A. Balen.  Surgical treatment of polycystic ovary syndrome. , 2006, Best practice & research. Clinical endocrinology & metabolism.

[15]  H. Fouad,et al.  Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio. , 2006, Fertility and sterility.

[16]  W. R. Sulaiman,et al.  Comparison of two aromatase inhibitors in women with clomiphene‐resistant polycystic ovary syndrome , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[17]  P. Bossuyt,et al.  Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial , 2004, BMJ : British Medical Journal.

[18]  K. Michels,et al.  Chromatin fluorescence characteristics and standard semen analysis parameters: correlations observed in andrology testing among 136 males referred for infertility evaluation , 2004, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[19]  R. Casper,et al.  Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility , 2003 .

[20]  R. Casper,et al.  A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. , 2002, Fertility and sterility.

[21]  C. Farquhar,et al.  A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. , 2002, Fertility and sterility.

[22]  R. Casper,et al.  Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. , 2001, Fertility and sterility.

[23]  C. Bondy,et al.  Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. , 1999, Biology of reproduction.

[24]  Redman Cw.  The use of antihypertensive drugs in hypertension in pregnancy. , 1977 .

[25]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[26]  R. Casper,et al.  Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. , 2003, Human reproduction.